← Back to Clinical Trials
Recruiting NCT06539104

NCT06539104 Aftificial Inteligence in Assisted Reproductive Techniques to Assess Oocyte Quality and Embryo Ploidy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06539104
Status Recruiting
Phase
Sponsor Charles University, Czech Republic
Condition Infertility
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2024-01-05
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 49 Years
Study Type OBSERVATIONAL
Interventions
arteficial inteligence evaluation of oocyte and embryo development

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2024-01-05 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The assisted reproduction success rate is affected by several factors including the age of the women, oocyte quality and maturation state, as well as sperm quality. Imaging of the meiotic spindle may be crucial for determining the oocyte maturation. Artificial intelligence (AI) will be applied to establish the complex oocyte quality, embryo ploidy and pregnancy success probability from the sequence of data, starting with the recording of the meiotic spindle in polarized light, through paternal factors up to the time lapse recording of early embryo development. This strategy should reduce the cost of fertility treatment thanks to increased efficiency in choosing the most promising candidates and reducing the need for costly laboratory analyses.

Eligibility Criteria

Inclusion Criteria: * Intracytoplasmatic Sperm Injection * Preimplantation genetic testing * Time lapse embryo record * Singned informed consent Exclusion Criteria: * Gynecological diseases * Genetical diseases of parents

Contact & Investigator

Central Contact

Jaromir Masata, MD

✉ masata@volny.cz

📞 +420603444662

Frequently Asked Questions

Who can join the NCT06539104 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 49 Years, studying Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06539104 currently recruiting?

Yes, NCT06539104 is actively recruiting participants. Contact the research team at masata@volny.cz for enrollment information.

Where is the NCT06539104 trial being conducted?

This trial is being conducted at Prague, Czechia, Prague, Czechia, Prague, Czechia, Vestec, Czechia.

Who is sponsoring the NCT06539104 clinical trial?

NCT06539104 is sponsored by Charles University, Czech Republic. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology